Jul 22, 2026

We did it — the FDA heard us. After a meeting with uniQure, the agency reversed course and agreed the existing AMT-130 data can support an accelerated approval application. Thank you to everyone who signed and stood with us — this victory is yours.

Copy link
WhatsApp
Facebook
Nextdoor
Email
X